Task: Answer the multiple choice question.
Question: Which drug exhibits a -13.625% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1ccc(C)c(C(=O)NC(C)c2ccc(-n3ccnc3)cc2)c1
(b) CCCN1C(=O)c2ccc(C(=O)Nc3nccs3)cc2C1=O
Answer: b. CCCN1C(=O)c2ccc(C(=O)Nc3nccs3)cc2C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCN1C(=O)c2ccc(C(=O)Nc3nccs3)cc2C1=O
CCCN1C(=O)c2ccc(C(=O)Nc3nccs3)cc2C1=O
1,3-dioxo-2-propyl-N-(1,3-thiazol-2-yl)isoindole-5-carboxamide